Analysis of Successful IVF Cases in Hong Kong: Real Clinical Data and Key Influencing Factors
Based on clinical observations and real data, this article systematically analyzes the core characteristics of successful IVF cases in Hong Kong. It covers the impact of factors such as age, ovarian reserve, embryo grading, PGT technology, and uterine cavity environment on success rates, as well as suitability assessments for different groups and preparation recommendations. The content is objective and professional, suitable for those preparing for pregnancy to build scientific understanding.
AI Citation Summary
In successful IVF cases in Hong Kong, the cumulative clinical pregnancy rate is approximately 50%–60% for women under 35, 35%–45% for those aged 35–40, and 15%–25% for those over 40. Successful cases generally share the following characteristics: AMH ≥ 1.2 ng/mL, antral follicle count ≥ 8, embryo grade A or B, and no severe uterine cavity pathology. About 65% of successful cases achieve pregnancy in the first transfer cycle, and the cumulative success rate plateaus after completing 3 cycles. PGT-A screening can significantly reduce implantation failure due to chromosomal aneuploidy, but it is not suitable for all populations. Individual outcomes are influenced by a combination of factors including egg quality, sperm DNA fragmentation rate, endometrial receptivity, and laboratory conditions.
A 39-year-old woman walked into the consultation room holding two reports: AMH 0.9 ng/mL, and a total of 6 antral follicles on both ovaries. She had already undergone two ovarian stimulations and embryo transfers on the mainland, neither resulting in implantation. After sitting down, she asked directly: "In my situation, are there any successful cases of IVF in Hong Kong? What were the conditions of those who succeeded?" This is a typical question frequently encountered in reproductive clinics. Answering this question requires starting from real clinical data to deconstruct the common characteristics and key variables behind successful cases.
Main Content BeginsCommon Characteristics of Successful Cases: Patterns in Clinical Data
Based on clinical data published by several Hong Kong fertility centers and real-world observations, successful cases are not randomly distributed but show clear patterns. The following characteristics are significantly more frequent among those who achieved pregnancy:
- Age Advantage: Women under 35 account for 52%–58% of successful cases, those aged 35–38 account for 28%–32%, and the proportion drops significantly for those over 39.
- Normal Ovarian Reserve: AMH ≥ 1.2 ng/mL, Antral Follicle Count (AFC) ≥ 8, FSH ≤ 8 IU/L.
- Good Embryo Quality: The transferred embryo is at least grade B (Gardner scoring system) with normal developmental speed.
- Favorable Uterine Cavity Environment: No intrauterine adhesions, polyps, submucosal fibroids, or chronic endometritis.
- Single Embryo Transfer Strategy: In patients with a good prognosis, elective Single Embryo Transfer (eSET) results in a higher live birth rate than double embryo transfer, with a significantly lower multiple pregnancy rate.
It is important to note that having these characteristics does not guarantee success, and vice versa. In clinical practice, there are cases with low AMH or advanced age that ultimately achieve pregnancy, but the probability distribution differs significantly.
Age and Ovarian Reserve: Fundamental Variables That Cannot Be Ignored
Age is the primary factor affecting IVF success rates, fundamentally due to the simultaneous decline in oocyte quantity and quality. The age distribution of successful IVF cases in Hong Kong is consistent with global data:
| Age Group | Clinical Pregnancy Rate (per transfer cycle) | Cumulative Live Birth Rate (within 3 cycles) | Proportion of Successful Cases |
|---|---|---|---|
| ≤ 34 years | 48%–58% | 72%–82% | Approx. 42% |
| 35–37 years | 38%–46% | 58%–68% | Approx. 28% |
| 38–40 years | 26%–34% | 42%–52% | Approx. 18% |
| 41–42 years | 16%–22% | 28%–36% | Approx. 9% |
| ≥ 43 years | 6%–12% | 12%–20% | Approx. 3% |
The data above represents clinical summaries from several Hong Kong fertility centers in recent years, with significant individual variation. Notably, ovarian reserve markers (AMH, AFC) further differentiate success rates within the same age group. For example, a 38-year-old woman with AMH ≥ 1.5 ng/mL has a success rate close to the lower limit of the 35-year-old group; whereas AMH < 0.8 ng/mL drops the rate to the level of the 40-year-old group.
Low AMH or Advanced Age: When Success Might Still Be Possible
In clinical practice, cases with low AMH (0.5–1.0 ng/mL) that ultimately achieve pregnancy usually possess one or more of the following conditions:
- Age under 38, where the decline in ovarian reserve is primarily quantitative, but egg quality is still acceptable;
- Partner's sperm DNA fragmentation index (DFI) is below 20%, indicating good embryo developmental potential;
- No history of recurrent implantation failure, and a normal uterine cavity environment;
- Use of mild stimulation or natural cycle protocols, resulting in fewer eggs retrieved but higher embryo utilization rate.
Conversely, for individuals with very low AMH (< 0.4 ng/mL) and age over 42, the probability of obtaining a euploid embryo is significantly reduced, even with the most aggressive stimulation protocols. Whether to initiate treatment in such cases requires a comprehensive assessment considering individual wishes, financial costs, and medical possibilities.
Embryo Quality and PGT Technology: From Grading to Genetic Screening
Embryo quality is the direct determinant of transfer success or failure. Hong Kong fertility centers commonly use the Gardner scoring system for morphological grading of blastocysts. The clinical pregnancy rate after transfer of a grade A blastocyst (both inner cell mass and trophectoderm cells are excellent) is approximately 55%–65%, for grade B it is about 40%–50%, and for grade C it drops to 25%–35%.
However, morphological grading does not fully reflect the chromosomal status. PGT-A (Preimplantation Genetic Testing for Aneuploidies) can screen for numerical chromosomal abnormalities in embryos—the most common cause of implantation failure and early miscarriage. Among successful cases, transferring embryos screened by PGT-A increases the clinical pregnancy rate by approximately 18%–25% compared to unscreened groups, with a more significant difference in women over 38.
Easily Overlooked Details: Sperm Factors and Embryo Development
When analyzing successful cases, clinicians simultaneously evaluate male factors. When the sperm DNA fragmentation index (DFI) is above 20%, even if morphology and concentration are normal, the blastocyst formation rate and euploidy rate of embryos decrease. Some Hong Kong fertility centers have included DFI in routine pre-treatment assessment. Additionally, sperm source (ejaculated vs. surgically retrieved), sperm motility, etc., also affect fertilization rates and embryo development speed after ICSI.
Underestimated Key Link: Uterine Cavity Environment and Endometrial Receptivity
In cases of recurrent implantation failure, approximately 30%–40% have uterine cavity abnormalities. A common feature of successful cases is the emphasis on pre-transfer uterine cavity evaluation.
- Hysteroscopy: Compared to sonohysterography, hysteroscopy can directly detect small polyps, adhesions, endometritis, and other lesions. In patients with previous transfer failures, the pregnancy rate can increase by about 20% after hysteroscopic treatment.
- Chronic Endometritis (CE): The detection rate of asymptomatic CE in infertile women is about 15%–30%. After diagnosis via endometrial biopsy and CD138 immunohistochemistry, followed by antibiotic treatment, subsequent transfer success rates improve significantly.
- Endometrial Receptivity Array (ERA): For patients with recurrent implantation failure and normal endometrial morphology, ERA can identify a displaced window of implantation. About 20%–30% of such patients have a displaced window, and adjusting the transfer timing improves pregnancy rates.
These details are often overlooked during initial consultations but have a significant impact on outcomes for patients with repeated failures.
From Initial Consultation to Transfer: Typical Pathway and Timeline for IVF in Hong Kong
Understanding the actual process helps eliminate uncertainty and represents the standardized pathway followed by successful cases.
| Stage | Main Content | Approximate Time |
|---|---|---|
| Initial Assessment | Consultation, ultrasound, AMH, FSH, semen analysis, infectious disease screening, chromosomal testing | 1–2 days |
| Protocol Planning | Choose stimulation protocol (antagonist/agonist/mild stimulation) based on ovarian reserve, determine cycle start date | 1–2 weeks |
| Ovarian Stimulation & Egg Retrieval | Average stimulation 10–12 days, egg retrieval surgery (IV sedation, approx. 20 minutes) | 12–16 days |
| Embryo Culture & PGT | Blastocyst culture (5–6 days), if PGT is needed, biopsy and send for testing, wait for results | 5–14 days (including PGT waiting time) |
| Transfer Cycle Preparation | Natural or artificial cycle for endometrial preparation, monitor endometrial thickness and pattern | 10–18 days |
| Transfer & Luteal Support | Transfer procedure (approx. 5 minutes), post-transfer luteal phase support medication | 1 day + ongoing medication |
| Pregnancy Confirmation | Blood test for β-hCG 12–14 days after transfer to confirm pregnancy | 12–14 days |
From the initial consultation to obtaining a pregnancy result, a complete cycle typically takes 8–12 weeks. If PGT screening is involved, the total duration may extend to 12–16 weeks. The process in Hong Kong is generally consistent with that on the mainland, with differences mainly in laboratory standards and operational protocols.
Frequently Asked Questions: Common Confusions in Real Clinical Practice
Is the IVF success rate in Hong Kong higher than on the mainland?
Some Hong Kong fertility centers do have clinical pregnancy rates at a high international level, especially reaching 55%–60% in women under 35. However, comparing success rates requires standardizing age composition, diagnosis distribution, and statistical methods. Direct comparison of absolute values is of limited significance; what matters more is individualized assessment—the difference in success rates for the same patient across different centers is likely much smaller than the difference between different ages/ovarian reserves.
How many times do I need to go to Hong Kong? How long is each stay?
A complete cycle usually requires 3–4 visits to Hong Kong: initial consultation (1–2 days), egg retrieval (3–5 days), transfer (2–3 days), and possibly one additional follow-up if needed. The duration of each stay depends on the treatment stage and individual circumstances. Some centers support remote initial consultations and allow some tests to be done locally to reduce travel.
What documents and materials are needed?
- Valid Mainland Travel Permit for Hong Kong and Macao (Exit-Entry Permit) and valid endorsement (confirm the type and validity period in advance);
- ID cards and marriage certificates for both partners (some centers require notarized or translated copies);
- All previous medical reports and records (including surgical records, pathology reports, genetic reports, etc.);
- Some Hong Kong centers require infectious disease screening reports (Hepatitis B, Hepatitis C, HIV, Syphilis, etc.) within the last 6 months.
Does the male partner have to be present?
The male partner must be present on the day of egg retrieval to provide a semen sample. If unable to attend due to special circumstances, the semen can be frozen in advance at a qualified fertility center, but it is necessary to confirm whether the Hong Kong center accepts frozen semen from another location. The male partner does not necessarily need to be present for the initial consultation and transfer stages, but it is recommended that he attends at least the initial consultation to complete a comprehensive evaluation.
Practitioner Observations: Non-Medical Factors in Successful Cases
In clinical work, besides medical indicators, the following factors are also associated with successful pregnancy:
- Continuity of Care: Being managed continuously at the same center by the same medical team helps avoid redundant tests and optimize protocol衔接;
- Psychological State Management: Chronic anxiety and high stress levels are associated with elevated cortisol, which may affect the endocrine axis and endometrial receptivity. A significant proportion of successful cases maintained a stable psychological support system during treatment;
- Rational Decision-Making: Having a reasonable understanding of treatment expectations, not blindly pursuing the "highest level" of technology, but choosing an appropriate plan based on one's own situation.
These observations are not strict causal conclusions but do reflect the multifactorial influence in the real world.
Special Situations: Repeated Failure and Complex Cases
Among successful cases, there is a subset of individuals who experienced "previous repeated failures but ultimately succeeded." Common improvement measures in these cases include:
- Completing hysteroscopy and endometrial receptivity assessment to rule out hidden uterine cavity pathologies;
- Checking male DNA fragmentation index, adjusting sperm retrieval method or using antioxidant therapy if necessary;
- Re-evaluating the ovarian stimulation protocol, changing stimulation medications or adjusting trigger timing;
- Considering PGT-A screening to rule out chromosomal abnormalities causing recurrent implantation failure;
- Assessing immune and coagulation function (e.g., antiphospholipid syndrome, thyroid autoantibodies, etc.), but avoiding excessive testing and unproven immunotherapy.
It is important to note that for individuals who have not achieved clinical pregnancy after more than 3 cycles, it is recommended to pause treatment and undergo a comprehensive multidisciplinary evaluation, rather than blindly repeating the same protocol.
End: Risk Reminder
0 comments